Search
The WasteWatcherTrump Administration Should Clearly Reject Socialized Medicine
Free-market fiscal conservatives are scratching their heads.
The WasteWatcherImporting Foreign Drugs Will Not Lower Drug Costs
This morning, the Department of Health and Human Services (HHS) announced a Notice of Proposed Rule Making (NPRM) to review two potential ways to allow “safe” im
The WasteWatcherKamala Harris's Medicare for All Plan: Just Another Gateway to Socialized Healthcare
Bottom line: Sen. Harris’s plan is just another entry way to force government-run healthcare on everyone.
The WasteWatcherIs the Prescription Drug Pricing Reduction Act Another Obamacare?
For weeks, there was little information on what would be in the legislation since it was being discussed and written behind closed doors.
The WasteWatcherColorado and California Take Action to Lower Obamacare Premiums
A July 23, 2019 Inside Health Policy healthcare column discusses predictions made by Colorado and California state officials on the cost of their insurance premiums in 2
The WasteWatcherSocialist Drug Price Controls Should be Rejected
It has been often said that in Washington, D.C. bad news comes out on a Friday afternoon and today, July 19, 2019, is no exception
The WasteWatcherV.P. Biden's Plan is Really a Side Door to Medicare for All
Today, former Vice President and 2020 Democratic presidential candidate Joe Biden offered his healthcare plan, the “Affordable Care Act 2.0.” It would keep and build on Obamacare and provide a public option or mechanism for people to buy into a gove
The WasteWatcherCAGW Weighs In on Important Announcements on Drug Pricing
Two important news items regarding pharmaceutical prices have been announced within the past week: a judge’s decision on a Trump administration rule that would have forced drug companies to provide the wholesale acquisition cost (WAC) of a drug in...
The WasteWatcherSenate Finance Committee Drug Pricing Changes - Market Driven or More Destructive Price Controls?
The healthcare policy community is anxiously waiting to see what kind of pharmaceutical pricing legislation Senate Finance Committee Chairman Chuck Grassley (R-Iowa) and Ranking Member Ron Wyden (D-Ore.) will produce for Medicare and Medicaid drug...
The WasteWatcherHang Onto Your Wallets ... And Your Freedom
Listening to the Democratic presidential debates these past two days has been alarming. Pandering to specific groups, the candidates are prepared to have the federal government cover the costs for a myriad of programs.
The WasteWatcherNo More Vaping in San Francisco?
The Los Angeles Times’s June 24 editorial, “San Francisco’s E-cigarette Ban Isn’t Just Bad Policy, it’s Ba
The WasteWatcherCreating a New Environmental Crisis
It has been said that one should never let a serious crisis go to waste. It could just as easily be said, “if there is no crisis, make one up to try to compel action and raise money.”
